Sage Journals: Discover world-class research

Free access

Research article

First published 2007-1

Clinical Management of Cutaneous Toxicity of Anti-EGFR Agents

M. Monti, S. Motta

The International Journal of Biological Markers

Open access

Review article

First published 2009

Safety and Efficacy of Panitumumab in the Treatment of Metastatic Colorectal Cancer

Daniel J. Freeman

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 2007-03

Renal Cell Cancer and Sorafenib: Skin Toxicity and Treatment Outcome

Emilio Bajetta, Giuseppe Procopio, Elena Verzoni [...]

Tumori Journal

Open access

Research article

First published 2020

Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?

Emanuela Dell’Aquila, Tea Zeppola, Marco Stellato [...]

Clinical Medicine Insights: Oncology

Retricted access

Case report

First published 2022-6

Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer

Mustafa Korkmaz, Engin Hendem, Melek Karakurt Eryılmaz [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2012-07

The Management of Skin Toxicity during Cetuximab Treatment in Advanced Colorectal Cancer: How much does it Cost? A Retrospecive Economic Assessment from a Single-Center Experience

Jacopo Giuliani, Monica Indelli, Marina Marzola [...]

Tumori Journal

Free access

Review article

First published 2015-9

Management of regorafenib-related toxicities: a review

Saravanan K. Krishnamoorthy, Valerie Relias, Sunit Sebastian [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2011-6

Clinical Observation of 73 Nasopharyngeal Carcinoma Patients Treated by Helical Tomotherapy: The China Experience

G. Ren, L. Du, L. Ma [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2025

A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)

Bora Lim, Angela Marx, Megumi Kai [...]

Therapeutic Advances in Medical Oncology

Search results